What you need to know about the new COVID-19 variants

A biologist who studies the evolution of diseases explains what's different about the two new virus strains that have been found recently, and what that means for vaccine effectiveness.

David Kennedy, Assistant Professor of Biology, Penn State • conversation
Jan. 15, 2021 ~7 min

evolution covid-19 coronavirus vaccines mutation

The simple reason West Virginia leads the nation in vaccinating nursing home residents

West Virginia turned to its local pharmacies for help. Its program's success holds some important lessons for other states and the rest of the vaccine rollout.

Tinglong Dai, Associate Professor of Operations Management & Business Analytics, Johns Hopkins Carey Business School, Johns Hopkins University School of Nursing • conversation
Jan. 14, 2021 ~6 min

covid-19 coronavirus statistics health-care sars-cov-2 pharmacy pandmics us-health-care

The great polio vaccine mess and the lessons it holds about federal coordination for today's COVID-19 vaccination effort

Massive vaccine distribution efforts take a lot of coordination. The rollout of the Salk polio vaccine in the US in 1955 holds lessons for those delivering COVID-19 shots today.

Bert Spector, Associate Professor of International Business and Strategy at the D'Amore-McKim School of Business, Northeastern University • conversation
Jan. 14, 2021 ~8 min

covid-19 vaccines polio vaccination covid-19-vaccine polio-vaccination polio-vaccine jonas-salk polio-immunisation vaccine-rollout

Almost half of NHS critical care staff show symptoms of PTSD, depression or anxiety

Almost half of NHS critical care staff suffered mental health issues in summer – now the situation is worse.

Kavita Vedhara, Professor of Health Psychology, Faculty of Medicine & Health Sciences, University of Nottingham • conversation
Jan. 14, 2021 ~7 min

 mental-health  covid-19  ptsd  coronavirus-insights  nhs-staff

The price of a drug should be based on its therapeutic benefits – not just what the market will bear

'Orphan drugs' with high price points are being tested as treatments for COVID-19. There's a better way to spur low-cost innovation for new drugs.

Nicole Hassoun, Professor of Philosophy, Binghamton University, State University of New York • conversation
Jan. 13, 2021 ~9 min

covid-19 rheumatoid-arthritis remdesivir pharmaceutical-industry drug-development innovation-and-invention process-of-innovation gilead

First lockdown's effect on air pollution was overstated, our study reveals

Exaggerating how much lockdown improved air quality could allow us to underestimate the scale of the air pollution problem.

William Bloss, Professor of Atmospheric Science, University of Birmingham • conversation
Jan. 13, 2021 ~7 min

covid-19 pandemic air-pollution transport-emissions lockdown nitrogen-dioxide pm-25 air-quality ozone

Americans have unrealistic expectations for a COVID-19 vaccine

Two in five Americans say they don't want a COVID-19 vaccine, which is a problem. Finding out what Americans do want from a vaccine might help.

Matt Motta, Assistant Professor of Political Science, Oklahoma State University • conversation
Jan. 13, 2021 ~9 min

covid-19 coronavirus vaccines herd-immunity covid-19-vaccine vaccine-safety vaccine-hesitancy moderna-vaccine pfizer-vaccine

The scent of sickness: 5 questions answered about using dogs – and mice and ferrets – to detect disease

Scientists are experimenting with using dogs to sniff out people infected with COVID-19. But dogs aren't the only animals with a nose for disease.

Glen J. Golden, Research Scientist/Scholar I, Colorado State University • conversation
Jan. 13, 2021 ~8 min

infectious-diseases covid-19 dogs mammals mice smell air-travel odor olfaction disease-surveillance avian-flu animal-training

COVID vaccine: some waste is normal – but here's how it is being kept to a minimum

With reports emerging of vaccine wastage across the world, medical supply chain experts explain why that's to be expected.

Liz Breen, Director of the Digital Health Enterprise Zone (DHEZ), University of Bradford, Reader in Health Service Operations, University of Bradford • conversation
Jan. 11, 2021 ~8 min

covid-19 supply-chains astrazeneca pfizerbiontech-vaccine vaccine-distribution vaccine-roll-out covid-vaccine

Delaying second COVID-19 vaccine doses will make supplies last longer but comes with risks

With vaccine shortages looming, experts are debating whether it is important to receive two doses or whether it's better to give one dose to more people and give a second when the supply is better.

Sanjay Mishra, Project Coordinator & Staff Scientist, Vanderbilt University Medical Center, Vanderbilt University • conversation
Jan. 11, 2021 ~11 min

 covid-19  coronavirus  immune-system  pandemic  t-cells  antibodies  sars-cov-2  moderna  astrazeneca  pfizerbiontech-vaccine

/

84